FDA Aims To Clarify Human Cell/Tissue Regulation With Upcoming Meeting, Guidance Documents
This article was originally published in The Gray Sheet
Executive Summary
FDA announced an April hearing to discuss four open draft guidance documents clarifying the regulation of human cells, tissues, or cellular or tissue-based products.